LYNSAFE-600 (Linezolid Tablets IP 600 mg)

LYNSAFE-600 (Linezolid Tablets IP 600 mg)

Brand Name: LYNSAFE-600
Medicine Form: Tablets

Composition:

• Linezolid: A synthetic antibiotic belonging to the oxazolidinone class. Linezolid works by inhibiting bacterial protein synthesis, which is essential for bacterial growth and multiplication. By interfering with the function of the ribosomes in bacteria, Linezolid prevents the formation of proteins necessary for bacterial survival, thus halting the infection. It is particularly effective against Gram-positive bacteria, including drug-resistant strains like Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococci (VRE).

Packaging Size: 1×10 tablets
Packaging Type: Blister Pack

Storage Instructions:

• Store in a cool, dry place.
• Keep away from direct sunlight and moisture.
• Keep out of reach of children.

Treatment: LYNSAFE-600 (Linezolid Tablets) is a potent antibiotic designed for the treatment of serious bacterial infections, particularly those caused by multidrug-resistant organisms. It is effective against a wide range of Gram-positive bacteria, including some of the most challenging, drug-resistant pathogens.

Linezolid is commonly used to treat infections that have not responded to other antibiotics, such as MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococci). These resistant strains often cause severe infections, including pneumonia, skin and soft tissue infections, and bloodstream infections.

• Pneumonia: Linezolid is an effective treatment for community-acquired and hospital-acquired pneumonia, especially when caused by drug-resistant bacteria.
• Skin and Soft Tissue Infections: It is used to treat complicated skin and soft tissue infections, including abscesses and ulcers caused by resistant bacteria.
• Bloodstream Infections: Linezolid is also used in the management of serious bloodstream infections caused by resistant organisms.
• Other Drug-Resistant Infections: It is used for treating VRE and other infections caused by bacteria resistant to common antibiotics.

LYNSAFE-600 Tablets offer a critical solution for treating serious infections caused by resistant bacteria. Its broad-spectrum efficacy and ability to combat resistant organisms make it a vital option for managing severe and complex infections. Suitable for adults, LYNSAFE-600 provides fast-acting relief, particularly in cases where other antibiotics have proven ineffective, ensuring better patient outcomes in severe bacterial infections.